Literature DB >> 33329937

[68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Frédéric Bois1, Camille Noirot1, Sébastien Dietemann1, Ismini C Mainta1, Thomas Zilli2,3, Valentina Garibotto1,3, Martin A Walter1,3,4.   

Abstract

Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool for managing patients with recurrent prostate cancer, and one of the most frequently employed radiopharmaceuticals is [68Ga]Ga-PSMA-11. Herein, we summarize the preclinical development and the clinical applications of [68Ga]Ga-PSMA-11 and present side-by-side comparisons with other radiopharmaceuticals or imaging modalities, in order to assist imagers and clinicians in recommending, performing, and interpreting the results of [68Ga]Ga-PSMA-11 PET scans in patients with prostate cancer. AJNMMI
Copyright © 2020.

Entities:  

Keywords:  PSMA; Prostate cancer; molecular imaging; restaging; staging

Year:  2020        PMID： 33329937      PMCID： PMC7724278     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  196 in total

Review 1.  Clinical Experience with 18F-Labeled Small Molecule Inhibitors of Prostate-Specific Membrane Antigen.

Authors:  Steven P Rowe; Michael A Gorin; Roberto A Salas Fragomeni; Alexander Drzezga; Martin G Pomper
Journal:  PET Clin       Date:  2017-01-23

2.  Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.

Authors:  Christoph Rischpler; Tobias Maurer; Markus Schwaiger; Matthias Eiber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-27       Impact factor: 9.236

3.  Incidental detection of tracer avidity in meningioma in 68Ga-PSMA PET/CT during initial staging for prostate cancer.

Authors:  T K Jain; A G S Jois; S Kumar V; S K Singh; R Kumar; B R Mittal
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2017-01-26       Impact factor: 1.359

4.  PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact.

Authors:  Bernhard Grubmüller; Pascal Baltzer; Sabrina Hartenbach; David D'Andrea; Thomas H Helbich; Alexander R Haug; Gregor M Goldner; Wolfgang Wadsak; Sarah Pfaff; Markus Mitterhauser; Theresa Balber; Neydher Berroteran-Infante; Marko Grahovac; John Babich; Christian Seitz; Gero Kramer; Martin Susani; Peter Mazal; Lukas Kenner; Shahrokh F Shariat; Marcus Hacker; Markus Hartenbach
Journal:  Clin Cancer Res       Date:  2018-08-23       Impact factor: 12.531

5.  Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.

Authors:  Thomas Hostiou; Albert Gelet; Jean-Yves Chapelon; Olivier Rouvière; Florence Mège-Lechevalier; Cyril Lafon; Hélène Tonoli-Catez; Lionel Badet; Sébastien Crouzet
Journal:  BJU Int       Date:  2019-07-02       Impact factor: 5.588

6.  Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer.

Authors:  Helle D Zacho; Julie B Nielsen; Ali Afshar-Oromieh; Uwe Haberkorn; Nandita deSouza; Katja De Paepe; Katja Dettmann; Niels C Langkilde; Christian Haarmark; Rune V Fisker; Dennis T Arp; Jesper Carl; Jørgen B Jensen; Lars J Petersen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-06       Impact factor: 9.236

7.  68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease.

Authors:  Arun Sasikumar; Ajith Joy; Raviteja Nanabala; M R A Pillai; Hari T A
Journal:  Clin Nucl Med       Date:  2016-10       Impact factor: 7.794

Review 8.  Whole-body diffusion-weighted MR imaging in cancer: current status and research directions.

Authors:  Anwar R Padhani; Dow-Mu Koh; David J Collins
Journal:  Radiology       Date:  2011-12       Impact factor: 11.105

9.  A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.

Authors:  J Schuhmacher; G Klivényi; W E Hull; R Matys; H Hauser; H Kalthoff; W H Schmiegel; W Maier-Borst; S Matzku
Journal:  Int J Rad Appl Instrum B       Date:  1992-11

10.  Impact of external cooling with icepacks on 68Ga-PSMA uptake in salivary glands.

Authors:  Ludwike W M van Kalmthout; Marnix G E H Lam; Bart de Keizer; Gerard C Krijger; Tessa F T Ververs; Rememrt de Roos; Arthur J A T Braat
Journal:  EJNMMI Res       Date:  2018-07-03       Impact factor: 3.138
View more
  13 in total

Review 1.  Advances in aptamer-based nuclear imaging.

Authors:  Wenyu Song; Yangmeihui Song; Qian Li; Chunhai Fan; Xiaoli Lan; Dawei Jiang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-08       Impact factor: 10.057

Review 2.  The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor.

Authors:  Antonia Högnäsbacka; Alex J Poot; Danielle J Vugts; Guus A M S van Dongen; Albert D Windhorst
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-05

Review 3.  A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer.

Authors:  Sara Brunello; Nicola Salvarese; Debora Carpanese; Carolina Gobbi; Laura Melendez-Alafort; Cristina Bolzati
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

4.  Metastatic hormone-sensitive prostate cancer: local treatment strategies.

Authors:  Francesco Montorsi; Alberto Martini; Giorgio Gandaglia; Nicola Fossati; Armando Stabile; Federico Dehò; Andrea Salonia; Alberto Briganti
Journal:  World J Urol       Date:  2021-03-17       Impact factor: 4.226

5.  First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers.

Authors:  Xiaoli Lan; Kevin Fan; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09       Impact factor: 10.057

6.  Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model.

Authors:  Paolo Dell'Oglio; Danny M van Willigen; Matthias N van Oosterom; Kevin Bauwens; Fabian Hensbergen; Mick M Welling; Huijbert van der Stadt; Elise Bekers; Martin Pool; Pim van Leeuwen; Tobias Maurer; Fijs W B van Leeuwen; Tessa Buckle
Journal:  EJNMMI Res       Date:  2022-03-07       Impact factor: 3.138

Review 7.  Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography: A Practical Guide for Radiologists and Clinicians.

Authors:  Fathima Fijula Palot Manzil; Harleen Kaur; Lajos Szabados
Journal:  Cureus       Date:  2022-03-07

8.  Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer.

Authors:  Mathieu Gaudreault; David Chang; Nicholas Hardcastle; Price Jackson; Tomas Kron; Gerard G Hanna; Michael S Hofman; Shankar Siva
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

9.  Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide.

Authors:  Carolina de Aguiar Ferreira; Pedram Heidari; Bahar Ataeinia; Nicoleta Sinevici; Alyssa Granito; Hritik Mahajan Kumar; Eric Wehrenberg-Klee; Umar Mahmood
Journal:  Pharmaceutics       Date:  2022-07-13       Impact factor: 6.525

10.  Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost.

Authors:  Brady S Laughlin; Alvin C Silva; Sujay A Vora; Sameer R Keole; William W Wong; Michael H Schild; Steven E Schild
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.